The global research antibodies and reagents market will grow at a CAGR of 6.5% from 2018 to 2023 to reach USD 13,276.5 million by 2023, according to latest publication from Meticulous Research®. The global research antibodies and reagents market is driven by various factors such as rising proteomics & genomic research studies, increase in the funding for research activities, and growing industry-academia collaborations. In addition, growing demand for protein therapeutics & personalized medicines, rising investment & focus on the area of stem cell research, need for new biomarker identification, and emerging Asia-Pacific and Latin American markets provides significant opportunities for various stakeholders in this market. However, various issues related to quality and stability of research antibodies such as cross-reactivity and storage conditions and intense pricing pressure on the leading players are the major challenges affecting the growth of research antibodies and reagents market to some extent.
Key Market Segments to Watch
The global research antibodies and reagents market is mainly segmented by product (reagents, and research antibodies), technology (western blotting, immunosorbent assays, immunofluorescence, immunohistochemistry, flow cytometry, immunoprecipitation, and others), application (proteomics, drug discovery & development, and genomics), end user (pharmaceuticals & biotechnology industry, academics & research institute, and contract research organizations), and geography.
Browse in-depth Report on: https://www.meticulousresearch.com/product/research-antibodies-reagents-market-2023/
On the basis of product type, reagents commanded the largest share in the global research antibodies and reagents market in 2017, mainly due to the huge demand for various reagents in many routine assays and techniques with increasing focus on understanding molecular basis of diseases and routine use in target based assays during the basic research.
On the basis of technology, western blotting held the largest share in the global research antibodies and reagents market in 2017. This was mainly attributed to increasing focus on biomedical research for initiating developments in diagnosis and therapy, rising funding for biomarker discovery, and raising demand for antibody & cell-based research and subsequent adoption of this technology in these research studies due to their high sensitivity & specificity to quantify the very low levels of proteins in the sample.
On the basis of application, proteomics held the largest share in the global research antibodies and reagents market in 2017. This was mainly attributed to rising uptake of research antibodies in the significantly growing proteomics market. The upsurge in proteomics research is attributed to the rising need for designing more effective drugs through protein based disease profiling, growing demand for personalized & protein therapeutics, and increasing public & private sector spending on proteomics research.
Based on end user, pharmaceutical and biotechnology industry commanded the largest share in 2017, due to the rising adoption of research antibodies & reagents in the proteomics research and drug discovery and development with the growing focus of industry vendors on innovating therapeutics for various chronic diseases.
Regional market growth trends
Geographically, this market is segmented into North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and RoE), Asia Pacific (Japan, China, India, and RoAPAC), Latin America, and Middle East & Africa. North America commanded the largest share in the global research antibodies and reagents market in 2017, followed by Europe and Asia-Pacific. However, Asia Pacific and Latin America regions are expected to witness significant growth during the forecast period, due to rapidly developing countries, rising preference for these regions due to cost effective research outsourcing, growing investment from government & non-government bodies in this sector, and various technological & infrastructure advancements.
Key players in the global market
The key players in the global research antibodies and reagents market are GE Healthcare (U.S.), Merck & Co., Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Amgen Inc. (U.S.), Sanofi (France), F. Hoffmann La-Roche Ltd (Switzerland), Rockland Immunochemicals Inc. (U.S.), Johnson & Johnson (U.S.), Agilent Technologies, Inc. (U.S.), Eli Lilly and Company (U.S.), Becton Dickinson and Company (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), GenScript Biotech Corporation (U.S.), Lonza (Switzerland), Bio-Techne Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Teva Pharmaceutical Industries Limited (Israel), Santa Cruz Biotechnology, Inc. (U.S.), BioLegend, Inc. (U.S.), Abcam PLC (U.K.), and Cell Signaling Technology, Inc. (U.S.).
Key questions answered in the report-
Request Sample Report:
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicated market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Meticulous Research® produces global reports and custom studies for North America, Europe, Latin America, Asia-Pacific, and the Middle East and Africa regions. These reports are used by our clients for marketing and strategic planning in various sectors.
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Connect with us on Twitter- https://twitter.com/MeticulousR123